Restricted accessResearch articleFirst published online 2011-1
Use of extracorporeal life support to support patients with acute respiratory distress syndrome due to H1N1/2009 influenza and other respiratory infections
A large proportion of critically ill H1N1/2009 patients with respiratory failure subsequently developed ARDS and, to date, about 400 patients receiving extracorporeal life support (ECLS) have been accounted for globally, with a reported survival rate from 63% to 79%. The survival rates of patients with ARDS due to non-H1N1/2009 infections are similar. There is no definite evidence to suggest that patient outcomes are changed by ECLS, but its use is associated with serious short-term complications.
ECLS relies on an extracorporeal circuit, with extracorporeal membrane oxygenation (ECMO) and pumpless interventional lung assist (ILA) being the two major types employed in ARDS. Both have the potential to correct respiratory failure and related haemodynamic instability. There are only a very limited number of clinical trials to test either and, although ECLS has been used in treating H1N1/2009 patients with ARDS with some success, it should only be offered in the context of clinical trials and in experienced centres.
Jain S., Kamimoto L., Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med2009 ; 361: 1935-1944.
2.
Louie JK, Acosta M., Winter K., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA2009; 302: 1896-1902.
3.
Kumar A., Zarychanski R., Pinto R., Cook D., Marshall J.Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA2009; 302: 1872-1879.
4.
Domínguez-Cherit G., Lapinsky S., Macias A., et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA2009; 302: 1880-1887.
5.
Archer B., Cohen C., Naidoo D., et al. Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases. Euro Surveill2009;14(42): pii: 19369.
6.
Sidebotham D. , McGeorge A., McGuinness S., Edwards M., Willcox T., Beca J.Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: Part 1-overview of extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth2009; 23: 886-892.
7.
Pollitt A.Subject: Extracorporeal Membrane Oxygenation (ECMO) in adults with potentially reversible respiratory failure (Reference 8894). NHS Specialized Commissioning Group2007.
8.
Schuerer DJ, Kolovos NS, Boyd KV, Coopersmith CMExtracorporeal membrane oxygenation: current clinical practice, coding, and reimbursement. Chest2008; 134: 179-184.
9.
Brogan T., Thiagarajan R., Rycus P., Bartlett R., Bratton S.Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Medicine2009; 35(12): 2105-2114.
10.
Bein T., Weber F., Philipp A., et al. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/ hypercapnia. Crit Care Med2006; 34: 1372-1377.
11.
Schmid C., Philipp A., Mueller T., Hilker M.Extracorporeal life support - systems, indications and limitations. Thorac Cardiov Surg2009; 57: 449-454.
12.
Extracorporeal Life Support Organization. www.elso.med.umich.edu/H1N1.htm (Accessed date 31st March 2010).
13.
Davies A., Jones D., Bailey M., et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA2009; 302: 1888-1895.
14.
Extracorporeal Life Support Organization (ELSO) ELSO Bibliography (April 2008). http://www.elso.med.umich.edu/Bibliography.html (Accessed date 31st March 2010).
15.
Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA1979; 242: 2193-2196.
16.
Morris AH, Wallace CJ, Menlove RL, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med1994; 149: 295-305.
17.
Peek GJ, Mugford M., Tiruvoipati R., et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet2009; 374: 1351-1363.
18.
Freed DH, Henzler D., White CW, et al. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anesth2010; 57: 240-247.
19.
Buckley E., Sidebotham D., McGeorge A., Roberts S., Allen SJ, Beca J.Extracorporeal membrane oxygenation for cardiorespiratory failure in four patients with pandemic H1N1 2009 influenza virus and secondary bacterial infection . Br J Anaesth2010; 104: 326-329.
20.
Suchyta MR, Clemmer TP, Orme JF, Jr., Morris AH, Elliott CGIncreased survival of ARDS patients with severe hypoxemia (ECMO criteria) . Chest1991; 99: 951-955.
21.
Peek GJ, Moore HM, Moore N., Sosnowski AW, Firmin RKExtracorporeal membrane oxygenation for adult respiratory failure. Chest1997; 112: 759-764.
22.
Kolla S., Awad SS, Rich PB, Schreiner RJ, Hirschl RB, Bartlett RHExtracorporeal life support for 100 adult patients with severe respiratory failure. Ann Surg1997; 226: 544-564; discussion 65-66.
23.
Lewandowski K., Rossaint R., Pappert D., et al. High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med1997; 23: 819-835.
24.
Ullrich R., Lorber C., Roder G., et al. Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS. Anesthesiology1999; 91: 1577-1586.
25.
Linden V., Palmer K., Reinhard J., et al. High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation. Intensive Care Med2000; 26: 1630-1637.
26.
Mols G., Loop T., Geiger K., Farthmann E., Benzing A.Extracorporeal membrane oxygenation: a ten-year experience. Am J Surg2000; 180: 144-154.
27.
Bartlett RH , Roloff DW, Custer JRExtracorporeal life support: The University of Michigan experience. JAMA2000; 283: 904-908.
28.
Frenckner B. , Palmér P., Lindén V.Extracorporeal respiratory support and minimally invasive ventilation in severe ARDS. Minerva Anesthesiol2002; 68: 381-386.
29.
Hemmila MR, Rowe SA, Boules TN, et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg2004; 240: 595-605.
30.
Gattinoni L. , Pesenti A., Mascheroni D., et al. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA1986; 256: 881-886.
31.
Brunet F., Belghith M., Mira JP, et al. Extracorporeal carbon dioxide removal and low-frequency positive-pressure ventilation. Improvement in arterial oxygenation with reduction of risk of pulmonary barotrauma in patients with adult respiratory distress syndrome . Chest1993; 104: 889-898.
32.
Liebold A., Reng CM, Philipp A., Pfeifer M., Birnbaum DEPumpless extracorporeal lung assist - experience with the first 20 cases. Eur J Cardiothorac Surg2000; 17: 608-613.
33.
Florchinger B., Philipp A., Klose A., et al. Pumpless extracorporeal lung assist: a 10-year institutional experience. Ann Thorac Surg2008; 86: 410-417.
34.
Muellenbach RM, Kredel M., Wunder C., et al. Arteriovenous extracorporeal lung assist as integral part of a multimodal treatment concept: a retrospective analysis of 22 patients with ARDS refractory to standard care. Eur J Anaesthesiol2008; 25: 897-904.
35.
Zimmermann M., Bein T., Arlt M., et al. Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Crit Care2009; 13: R10.
36.
Extracorporeal Life Support Organization (ELSO).ELSO H1N1 Specific Supplements to the ELSO General Guidelines . Ann Arbor, MI (www.elso.med.umich.edu ). November 2009.
37.
Extracorporeal Life Support Organization (ELSO).ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support. Ann Arbor, MI (www.elso.med.umich.edu ). April 2009.
38.
National Institute of Clinical Excellence (NICE).Interventional Procedure Guidance 39, Extracorporeal Membrane Oxygenation (ECMO) in Adult. 2004.
39.
National Institute of Clinical Excellence (NICE).Interventional Procedure Guidance 250.Arteriovenous extracorporeal membrane carbon dioxide removal . January 2008.
40.
Royal College of Anaesthetists’.Pandemic H1N1 2009 Clinical Practice Notes - Managing Critically Ill Cases . 2009.
41.
Davidson T. , Caldwell E., Curtis J., Hudson L., Steinberg K.Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients . JAMA1999; 281: 354-360.
42.
Chrispin PS , Scotton H., Rogers J., Lloyd D., Ridley SAShort Form 36 in the intensive care unit: assessment of acceptability, reliability and validity of the questionnaire . Anaesthesia1997; 52: 15-23.
43.
Jones PW, Quirk FH, Baveystock CMThe St George’s Respiratory Questionnaire. Respir Med1991; 85 Suppl B: 25-31.
44.
Folstein MF, Folstein SE, McHugh PR " Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189-198.
45.
Zigmond A., Snaith R.The hospital anxiety and depression scale. Acta Psychitr Scand1983; 67: 361-370.
46.
Robinson BCValidation of a Caregiver Strain Index. J Gerontol1983; 38: 344-348.
47.
Linden VB, Lidegran MK, Frisen G., Dahlgren P., Frenckner BP, Larsen F.ECMO in ARDS: a long-term follow-up study regarding pulmonary morphology and function and health-related quality of life. Acta Anaesthesiol Scand2009; 53: 489-495.
48.
Chang Y.-S, van Hal SJ, Spencer PM, Gosbell IB, Collett PWComparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the ‘PROTECT’ phase of response . Med J Aust2010; 192: 90-93.
